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Attitudes Toward Breast Cancer Genetic Testing in Five Special Population
Groups
Abstract
Purpose: This study examined interest in and attitudes toward genetic testing in 5 different population
groups.
Methods: The survey included African American, Asian American, Latina, Native American, and
Appalachian women with varying familial histories of breast cancer. A total of 49 women were
interviewed in person. Descriptive and nonparametric statistical techniques were used to assess ethnic
group differences.
Results: Overall, interest in testing was high. All groups endorsed more benefits than risks. There were
group differences regarding endorsement of specific benefits and risks: testing to “follow doctor
recommendations” (p=0.017), “concern for effects on family” (p=0.044), “distrust of modern medicine”
(p=0.036), “cost” (p=0.025), and “concerns about communication of results to others” (p=0.032). There
was a significant inverse relationship between interest and genetic testing cost (p
Conclusion: Cost may be an important barrier to obtaining genetic testing services, and participants
would benefit by genetic counseling that incorporates the unique cultural values and beliefs of each group
to create an individualized, culturally competent program. Further research about attitudes toward genetic
testing is needed among Asian Americans, Native Americans, and Appalachians for whom data are
severely lacking. Future study of the different Latina perceptions toward genetic testing are encouraged.
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ABSTRACT
Purpose: This study examined interest in and attitudes toward genetic testing in 5
different population groups.
Methods: The survey included African American, Asian American, Latina, Native
American, and Appalachian women with varying familial histories of breast cancer. A
total of 49 women were interviewed in person. Descriptive and nonparametric statistical
techniques were used to assess ethnic group differences.
Results: Overall, interest in testing was high. All groups endorsed more benefits than
risks. There were group differences regarding endorsement of specific benefits and risks:
testing to “follow doctor recommendations” (p=0.017), “concern for effects on family”
(p=0.044), “distrust of modern medicine” (p=0.036), “cost” (p=0.025), and “concerns
about communication of results to others” (p=0.032). There was a significant inverse
relationship between interest and genetic testing cost (p<0.050), with the exception of
Latinas, who showed the highest level of interest regardless of increasing cost.
Conclusion: Cost may be an important barrier to obtaining genetic testing services, and
participants would benefit by genetic counseling that incorporates the unique cultural
values and beliefs of each group to create an individualized, culturally competent
program. Further research about attitudes toward genetic testing is needed among Asian
Americans, Native Americans, and Appalachians for whom data are severely lacking.
Future study of the different Latina perceptions toward genetic testing are encouraged.
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INTRODUCTION
Breast cancer is the most common malignancy in U.S. women; one of eight women in the
U.S. will develop breast cancer at some time during their lives (NCI, 2013). Nearly 235,000
cases of breast cancer will be diagnosed in 2013. Breast cancer has a genetic component; 5-10%
of all breast cancer cases result from inherited mutations of the BRCA1 and BRCA2 genes (NCI,
2013). Lifetime risk of developing breast cancer greatly increases if a woman inherits a
mutation; 60% of women who have a BRCA1 or BRCA2 mutation will develop breast cancer
compared to 12% of women in the general population (NCI, 2013). Because tests for these
genetic mutations are now available and represent a means to reduce breast cancer morbidity and
mortality through primary prevention, the willingness of high-risk women to undergo genetic
counseling, if not also genetic testing, is of considerable interest.
Few studies have examined the knowledge and attitudes of women toward cancer genetic
testing, particularly among various special populations. Some studies suggest group variation in
genetic knowledge, perceived risks, attitudes towards testing, and acceptability of services
(Foster, Eisenbraun & Carter, 1997-1998; Hall & Olopade, 2006; Lagos et al., 2005). Basic
factors such as health literacy, education, and knowledge of anatomy and disease have been
shown to mediate the likelihood of obtaining genetic counseling and/or testing (Burhansstipanov,
Bemis, Kaur & Bemis, 2005; Chalela, Pagán, Su, Muñoz & Ramirez, 2012; Kelly, Andrews,
Case, Allard & Johnson, 2007).
An understanding of the attitudes of high-risk women toward breast cancer genetic
testing is necessary to develop appropriate and culturally sensitive educational materials and
programs. In this study, we examine these attitudes among women from five special population
groups: African American, Asian American, Latina, Native American, and Appalachians
(inhabitants of the Appalachian Region), focusing on the perception of benefits and risks of
genetic testing for breast cancer (Abraham & Sheeran, 2005).
METHODS
Participants and Procedures
The National Cancer Institute (NCI) Special Populations Networks (SPN) for Cancer
Awareness, Research, and Training program and the NCI Cancer Genetics Network partnered
with Susan G. Komen for the Cure to investigate attitudes toward and interest in breast cancer
genetic testing among five special population groups. The five SPN programs involved in this
project were: 1) Redes En Acción: The Natinal Latino Cancer Research Network, 2) Appalachia
Community Cancer Network (AACN), 3) Asian American Network for Cancer Awareness,
Research, and Training (AANCART), 4) National Black Leadership Initiative on Cancer, and 5)
American Indian/Alaskan Native Leadership Initiative on Cancer. This collaboration was
supported by a Komen grant and coordinated through the Chronic Disease Prevention and
Control Research Center at the Baylor College of Medicine, which granted IRB approval for this
study.
A Progress Review Group, consisting of a representative from each of the five national
SPN sites, a genetics expert representing each population, an epidemiologist, and advisory
members from the NCI and Komen oversaw development of the survey instrument, pretesting
and field implementation. Each SPN was responsible for recruiting representative participants,
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including “survivors” (women diagnosed with breast cancer), “moderate/high-risk” women
(those with a first-degree relative diagnosed with breast cancer age <50), and “low-risk” women
(those with no family history of breast cancer). Survivors and moderate/high-risk women were
recruited from cancer clinics, advocacy and support groups, cancer registries, and other
community clinics and organizations. Low-risk women were recruited from the general
community or through referrals. Survey participants were ages 25-64 and self-identified as one
of the five population groups; a total of 49 participants completed the survey as part of the
pretest phase of the study.
Measures
The survey instrument was based on items and scales used in previous genetics research
surveys among the Caucasian population. The instrument was revised and tested to achieve a 5th
to 7th grade reading level and technical terms were explained. The survey instrument, which
took about 45 minutes to complete, was administered face-to-face over a period of three months.
It included demographic questions and items assessing women’s knowledge, attitudes, and
behaviors toward breast cancer and breast cancer genetics, and a culture-specific section for each
group.
Perceived benefits and risks of genetic testing (e.g., attitudes) were assessed using a
validated questionnaire developed by Lerman and colleagues, evaluating self-efficacy and the
reasons “to test” or “not to test” (Lerman et al., 1997). Items related to interest in testing for a
breast cancer gene and likelihood of participation in genetic research were scored either as
dichotomous (yes, no) or on a Likert scale (higher number = greater level of interest/importance).
Analysis
To evaluate differences in attitude items between groups, we used the nonparametric KruskalWallis H comparison of mean ranks; Fisher’s Exact Tests were used to assess group differences
in proportions of specific attributes. A 2-sided p-value <0.05 was used to test for statistical
significance. All analyses were conducted using SPSS 19.0 for Windows (IBM Corporation,
2010).
RESULTS
All participants were born in the US except a portion of Asian and Latina groups (Table
1). The majority of women were high school educated, employed (with the exception of Latinas),
and reported that they had some form of health insurance. About half of the sample (44% to
50%) had received a breast cancer diagnosis and the majority had a close blood relative who was
diagnosed with cancer. There was a significant group difference in annual household income
with fewer Appalachian and Native American women in the above $50,000 category (p=0.020).
There were no other significant group differences in socio-demographic factors.
Table 2 shows the group variation in attitudes toward breast cancer genetic testing.
Regarding perceived benefits of testing, only one item, “I would want to be tested for a breast
cancer gene to follow my doctor’s recommendation,” differed across groups (p=0.022) with
Latinas placing the greatest importance on a doctor’s recommendation. Regarding reasons not to
test (e.g., perceived risks and limitations), 4 items showed statistically significant differences
between groups. These were “I am concerned about the effect it would have on my family”
(p=0.044); “I do not trust modern medicine” (p=0.014); “The test costs too much” (p=0.041);
and “I am concerned the results will be given to others without my permission” (p=0.032).
Appalachian women, followed by African Americans, had greatest concerns related to effects on
their family; Native Americans had the greatest distrust of modern medicine; Appalachians and
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African Americans were most concerned about the cost of testing; and finally, Native American
and Asian American women had the highest concerns about test results being given to others
without their permission. Overall, Latina women were least concerned about any of the
perceived risks and limitations to genetic testing.
Summing up the number of benefits that each woman felt was important, there were no
significant differences among the groups (mean number of endorsed benefits, Latinas, 9.2 ± 1.8,
African Americans 8.8 ± 1.4, Appalachians 8.3 ± 1.2, Native Americans 7.9 ± 2.3, Asian
Americans 6.0 ± 3.0). In contrast, the groups varied significantly in the number of risks that were
endorsed (p=0.002). The mean number of endorsed risks was 4.2 ± 2.2 for Appalachians; 4.7 ±
2.9, Asian Americans; 6.6 ± 2.8, Native Americans; and 7.6 ± 3.6, African Americans. No risk
was endorsed by Latinas.
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Table 1. Characteristics by Special Population Group

(N=10)

Asian
American
(N=10)

(N=10)

Native
American
(N=10)

46.0 + 7.2

46.1 + 18.4

51.6 + 10.8

41.8 + 10.6

51.1 + 3.1

Born in the US (%)

100.0

100.0

60.0

70.0

100.0

Married or Living as Married (%)

33.3

80.0

50.0

80.0

30.0

High School Education or more (%)

100.0

80.0

100.0

100.0

100.0

Employed (%)

85.7

50.0

80.0

40.0

80.0

Annual Household Income >50K

71.4

40.0

80.0

71.4

33.3

Have Children (%)

55.6

90.0

80.0

90.0

70.0

Have Health Insurance (%)

100.0

90.0

100.0

80.0

80.0

Breast Cancer Diagnosis (%)

44.4

50.0

50.0

50.0

50.0

Have Blood Relative w cancer (%)

100.0

100.0

70.0

80.0

90.0

Age (mean +- SD years)

African
American
(N=9)

Appalachian

Latina
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Table 2. Attitudes Towards Breast Cancer Genetic Testing Ethnic Group (Group Median Scores and Significance)
African American Appalachian
Asian
Latina
(N=9)
(N=10)
American
(N=10)
(N=10)
Reasons FOR breast cancer genetic testing
Learn about breast cancer risk
3
3
4
4
Learn about children’s risk
3
3
4
4
Provide information for family
3.5
3
2
4
Decide about hormone replacement
4
2
1.5
4
Make decisions about surgery
3
2
3
4
Know if I need cancer screening more often
3.5
3
3
4
Plan for the future
4
3
2
3
Make decisions about having kids
2
1
2
4
Follow my doctor’s recommendation
3
3
2
4
Follow family’s recommendation
2.5
2
2
4
Reasons AGAINST breast cancer genetic testing
Concerned about effect on family
2
2.5
1
1
Do not trust modern medicine
1
1
1
1
Nothing I could do to prevent cancer
2
1
1
1
Concerned could not handle it
1.5
1.5
1
1
Results might not be accurate
2
2
1
1
Worried about losing health insurance
2
1
3
1
Worried about losing life insurance
2
1
2
1
Worried about job discrimination
1
1
1.5
1
Worried about children’s health insurance
2
2
1
1
Test costs too much
3
3
2
1
Concerned about getting tested without
1.5
1
1.5
1
permission
Concerned others will get results without
2
1
2.5
1
permission
Don’t like to give blood for tests
1
1
1
1

Native
American p-value*
(N=10)
3
3
3
2
2.5
3
3
2
3
3

0.083
0.499
0.315
0.191
0.194
0.276
0.384
0.129
0.022
0.393

1.5
2
1
1
2
2
1
1
2
2.5

0.044
0.014
0.115
0.349
0.109
0.124
0.095
0.164
0.203
0.041

2

0.259

2.5

0.032

1

0.247

Response options:1=Not at all important; 2=Somewhat important; 3=Very important, 4=Extremely important
* Two-sided p-value from Kruskal Wallis H comparison of mean ranks
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Table 3. Interest in Genetic Testing and Research by Special Population Group

Ever talked with health professional
about genetic test (%)
Ever had a blood test to find breast
cancer gene (%)
Would Want to know whether you have
breast cancer gene (%)

African
American
(N=9)

Appalachian
(N=10)

Asian
(N=10)

Latina
(N=10)

Native
American
(N=10)

p-value*

22.2

0.0

33.3

22.2

22.2

0.548

22.2

0.0

0.0

11.1

0.0

0.109

88.9

100.0

100.0

90.0

88.9

0.528

Conditional Interest in breast cancer genetic testing (median scores)
If cost not issue, interested in
testing if family historya

3

3

3

3

3

0.642

Interested if it cost $200 to 500b

3

2.5

2

4

2

0.099

Interested if it cost $501 to 1000b

2.5

2

1.5

4

1

0.013

Interested if it cost $1001 to 2000b

1.5

1.5

1

4

1

0.027

1

1

1

2

1

0.041

3

3

3

4

2

0.618

3

3

2

4

1.5

0.355

Interested if it cost over $2000b
Be in study about genes and breast
cancerb
Give blood so scientists could study
cancerb
a

1=Not at all interested; 2=Somewhat interested; 3=Very interested
1=Definitely no; 2=Probably no; 3=Probably yes; 4=Definitely yes
* Two-sided p-value from Fisher’s Exact Test or Kruskal-Wallis H comparison of mean ranks
b
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Table 3 shows the items related to past participation in genetic research and interest in
genetic testing. Most women had not talked to a healthcare professional about genetic testing nor
had the test (67% to 89%). Nearly all women wanted to know their status regarding the breast
cancer gene. For the scenario, “If you had two close relatives with breast cancer, how interested
would you be in getting a blood test for a breast cancer gene?”—the groups differed in their
responses given specific test costs. Once costs increased to $501 or more, significant group
differences emerged (Table 3). Among the groups, Latinas consistently showed the highest level
of interest regardless of increasing cost, while Native Americans and Asian Americans had the
least interest in testing. There were no group differences in likelihood of participating in a
medical study or providing blood for genetic research.
DISCUSSION
This study showed some distinct group differences in attitudes toward breast cancer
genetic testing. For example, Latinas endorsed the greatest number of benefits of testing and
perceived the least number of risks. African American and Native American women endorsed
more risks than other groups. On the other hand, there was a generally positive attitude toward
genetic testing as each group endorsed more benefits than risks. This corroborates previous
research showing that most women rate BRCA genetic testing more beneficial than risky—
attitudes that can be enhanced with personalized counseling (Lerman et al., 1997).
Most Latinas endorsed each reason to be tested as “very” or “extremely” important.
Research has shown that, despite less knowledge, Latinas have positive attitudes toward testing
and find benefits of testing to be greater than associated risks (Chalela et al., 2012; Ramirez,
Aparicio-Ting, de Majors & Miller, 2006). Latinas also placed significantly more importance on
“following doctors’ recommendations” than other groups. In Latina culture, healthcare providers
are seen as authority figures whose opinions are to be respected and trusted (e.g., respeto)
(Chalela et al., 2012). Thus, physicians can have a strong influence on the uptake of genetic
breast cancer testing among high-risk Latino patients. Latina culture values family cohesiveness
(familismo), collectivism (allocentrism), and positive social exchange (simpatía). The desire to
have respectful relationships in a collective unit may influence how Latinas respond to queries
by healthcare professionals, which may explain the high endorsement of genetic testing observed
in this study. Healthcare providers should be cognizant of this cultural aspect (i.e., allocentrism
and simpatía) so that they can have a balanced perspective of their patient’s health care needs.
Our study showed a tendency for African American women to perceive more risks and
barriers, with cost being a large deterrent. Others have characterized this pessimism among
African Americans as a tendency to view the vulnerability to outside forces (Purnell & Paulanka,
2005). African Americans may also be less likely to be aware of their family history of cancer
and other diseases, which may impact their use of genetic services (Hall & Olopade, 2006).
Contrary to the long-held belief of medical disillusionment among the African American
community, African American women in this study were no more distrustful of modern medicine
than other groups. This contradicts previous studies reporting increased distrust of testing among
African American women due to negative historical experiences (Suther & Kiros, 2009;
Thompson, Valdimarsdottir, Jandorf & Redd, 2003). Family-related worry and guilt have also
been cited as barriers for African American women (Thompson et al., 2005). African American
women in our study tended to have greater concerns about the effects of genetic testing on their
families than some other groups. It has also been shown that testing intentions increase among
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African Americans when given the opportunity to discuss family and personal issues about
testing (Lerman et al., 1999).
In our study, Asian American women were less interested in paying for more expensive
testing than most other groups. This may be due to the competing demand of providing what is
important for their family versus what is important for individual needs. This conflict in
prioritizing family versus individual needs is well-documented in many studies focusing on
Asian American health issues. This finding is consistent with a study of Hong Kong Chinese
adults who placed more value on the wellbeing and reactions of family members than the
individual genetic testing (Ho, Ho, Chan, Kwan & Tsui, 2003), and another study reporting that
Japanese Americans were less interested than Caucasians in colon cancer genetic testing (Glanz,
Grove, Lerman, Gotay & Marchand, 1999). Though Asian Americans endorsed fewer benefits of
genetic testing, they also endorsed a small number of risks, suggesting that they may have a more
balanced view of the costs and benefits of genetic testing. A study in Singapore showed that
while there was initially very high interest in being tested, significant barriers existed that
resulted in low uptake: cost, losing control of medical information that may affect future
coverage, concern over emotional burden of genetic information, and perception of unchanging
medical management (Chieng & Lee, 2012). In our study, Asian American women were most
concerned about others getting test results without their permission.
To our knowledge, this is the only study to examine Appalachian women’s attitudes
toward and interest in breast cancer genetic testing. One study of rural Appalachian adults found
that younger age, family history of cancer, and greater worry predicted greater intention to seek
genetic testing for hereditary cancer (Kelly et al., 2007). Others have noted that Appalachians
face economic challenges including lower income, lack of employment, and poor or limited
healthcare resources (Paskett et al., 2011). In our study, Appalachian attitudes toward genetic
testing, perceived risks and benefits were mostly in line with other ethnic groups. However, as a
group they were more concerned about testing’s costs and effects on family. Aside from
economic concerns, it is unclear how Appalachian cultural attributes that emphasize religion and
self-reliance would affect the uptake of genetic testing.
Native Americans were more likely to distrust modern medicine and had more concerns
about the risk of others receiving test results without permission than other groups, reflecting a
historical struggle with stigmatization. Native Americans hold a general distrust of healthcare
due to a history of research testing with no apparent benefits to individuals (Burhansstipanov et
al., 2005; Burhansstipanov, Bemis & Petereit, 2009), and they are reluctant to participate in
genetic research and related activities (Burhansstipanov et al., 2009). Earlier research on Native
Americans about genetic testing showed that local sociocultural issues were more important than
issues such as insurance discrimination and employment (Foster et al., 1997-1998). Native
Americans value group membership, connections to the earth, wisdom of elders, and the success
and wellbeing of their community. Thus, culturally sensitive group counseling may be more
effective than individual counseling, especially with regard to genetic counseling and testing
(Calabrese, 2008). This approach may serve to protect not only individual rights but those of the
group as well. Because of the importance of community, tribal approval and the demonstration of
respect toward tribal values and beliefs are critical to successful genetic research in this
population.
A key finding in this study was cost as a barrier to genetic testing. Fewer women claimed
interest in genetic testing as the proposed cost of testing increased, with the exception of Latinas
who consistently claimed interest at each level of increasing cost. A previous study showed that
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Latinas and African Americans did not pursue testing as often as Caucasians, largely due to
financial and informational barriers (Singer, Antonucci & Van Hoewyk, 2004). Other studies
have reported cost as a barrier to genetic testing uptake among minorities (Peters, Rose &
Armstrong, 2004). BRCA genetic testing costs approximately $3,000 and more if additional
testing is required. While many patients have insurance coverage for testing, many cannot afford
the out-of-pocket expense (which can be several hundred dollars) and some types of insurance do
not cover adult genetic tests such as BRCA1, BRCA2, her2/NEU or triple negative. Many other
Americans are under-insured or uninsured, and Hispanics have the highest uninsured rate at
30.7% (DeNavas-Walt, Proctor & Smith, 2012). Thus, genetic testing could be financially out of
reach for women of diverse ethnicities.
Though this study was exploratory with limited sample size, it provides new information
on the attitudes toward breast cancer genetic testing among five special population groups that
face breast cancer health disparities of varying degrees. We note, however, that some of the
distinct differences in attitudes may have been due to bias related to social desirability, especially
among Latinas who may been compelled to show more interest in testing than they felt. The
small sample size did not allow a more thorough analysis of diversity within each ethic/racial
group, i.e., receptivity by risk status, breast cancer stage at diagnosis, etc., which warrants further
research. In addition, income may have contributed to the differences in attitudes toward genetic
testing; however the sample was too small for exploration of this issue. Finally, more formal
research is needed among the special populations of Asian Americans, Native Americans, and
Appalachians, for whom data are severely lacking.
CONCLUSION
In conclusion, this study found important cultural differences in attitudes about breast
cancer genetic testing, and interest in genetic testing and genetic research. An understanding of
cultural diversity among different special population groups is necessary for culturally competent
and ethnically centered care. Substantial emphasis should be placed on informing participants of
different ethno-cultural groups of the costs and benefits of testing. Researchers and healthcare
providers should also strive to increase understanding of the legitimate and accurate test costs
and opportunities for coverage and reimbursement. In addition, participants would benefit from
tailored educational strategies about genetic counseling and testing that incorporate the unique
cultural values and beliefs of each group to create an individualized, culturally competent
program.
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